DIA
Drug Information Association Logo
« Back to Listing

Why Does Drug Development Need Project Management?

Track:
Project/Portfolio Management and Strategic Planning

Day & Time:
June 18, 8:00AM - 9:00AM (Pacific Standard Time)

Session Number:
304

Room Number:
5A

Level:
Advanced

Type:
Session

Title:
Why Does Drug Development Need Project Management?

Chair(s):
Timothy M. Phelan, PhD
Executive Director
Merck & Co., Inc., United States

Description:
Bringing a new medicine to patients is one of the truest examples of project management, yet the business results for large pharmaceuticals suggest we have not fully realized the business benefit of applying project management theory and practice. This session will discuss how maximizing the project management infrastructure already installed in drug development organizations will improve their business results.

Learning Objective(s):
Describe how to drive business results with existing infrastructure; Discuss the balance between the art and science of project management; Explain real-world application.

Presentation(s) & Speaker(s):
Panelist
Vanessa Graham, MBA
Executive Director, Global Program Management
Amgen Inc., United States

Panelist
Jim L. Vandergriff
Manager, CT Material Supply Chain Planning
Eli Lilly and Company, United States